ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+13.95%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$50.1B
AUM Growth
+$5.82B
(+13%)
Cap. Flow
+$1.41B
Cap. Flow
% of AUM
2.82%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
2,219
New
138
Increased
857
Reduced
1,077
Closed
142
Top Buys
| 1 |
Shopify
SHOP
|
$191M |
| 2 |
NVIDIA
NVDA
|
$166M |
| 3 |
Microsoft
MSFT
|
$159M |
| 4 |
Apple
AAPL
|
$120M |
| 5 |
Amazon
AMZN
|
$96.8M |
Top Sells
| 1 |
W.W. Grainger
GWW
|
$155M |
| 2 |
Goldman Sachs
GS
|
$146M |
| 3 |
Consolidated Edison
ED
|
$44.8M |
| 4 |
Coca-Cola
KO
|
$36.1M |
| 5 |
Atmos Energy
ATO
|
$32.3M |
Sector Composition
| 1 | Technology | 35.67% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Industrials | 9.41% |
| 4 | Communication Services | 9.36% |
| 5 | Financials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
OraSure Technologies
OSUR
$230M
| $46.3K | ﹤0.01% |
15,419
-205
| -1% | -$615 |
|
2002
Krispy Kreme
DNUT
$582M
| $46K | ﹤0.01% |
15,819
-2,701
| -15% | -$7.86K |
|
2003
Editas Medicine
EDIT
$227M
| $45K | ﹤0.01% |
20,432
-1,234
| -6% | -$2.72K |
|
2004
The Beauty Health Co
SKIN
$255M
| $44.8K | ﹤0.01% |
23,447
+7,336
| +46% | +$14K |
|
2005
Allogene Therapeutics
ALLO
$246M
| $44.4K | ﹤0.01% |
39,260
+2,014
| +5% | +$2.28K |
|
2006
Berry Corp
BRY
$254M
| $43.8K | ﹤0.01% |
15,801
-782
| -5% | -$2.17K |
|
2007
OmniAb
OABI
$230M
| $43.7K | ﹤0.01% |
25,138
-962
| -4% | -$1.67K |
|
2008
iHeartMedia
IHRT
$342M
| $43K | ﹤0.01% |
24,453
+1,778
| +8% | +$3.13K |
|
2009
SELLAS Life Sciences
SLS
$187M
| $42.9K | ﹤0.01% |
+19,571
| New | +$42.9K |
|
2010
Safe Bulkers
SB
$451M
| $42.7K | ﹤0.01% |
11,818
-1,256
| -10% | -$4.53K |
|
2011
Aldeyra Therapeutics
ALDX
$332M
| $42.6K | ﹤0.01% |
11,127
+343
| +3% | +$1.31K |
|
2012
Denny's
DENN
$248M
| $42.4K | ﹤0.01% |
10,339
-575
| -5% | -$2.36K |
|
2013
WideOpenWest
WOW
$436M
| $42.1K | ﹤0.01% |
10,374
-448
| -4% | -$1.82K |
|
2014
Perspective Therapeutics
CATX
$263M
| $42K | ﹤0.01% |
12,220
+518
| +4% | +$1.78K |
|
2015
Prime Medicine
PRME
$606M
| $41.7K | ﹤0.01% |
16,871
-1,323
| -7% | -$3.27K |
|
2016
Omeros
OMER
$284M
| $41.3K | ﹤0.01% |
13,760
-961
| -7% | -$2.88K |
|
2017
United States Antimony
UAMY
$569M
| $40.9K | ﹤0.01% |
+18,782
| New | +$40.9K |
|
2018
Open Lending Corp
LPRO
$267M
| $40.8K | ﹤0.01% |
21,023
-1,097
| -5% | -$2.13K |
|
|
ALMS
2019
Alumis Inc. Common Stock
ALMS
$475M
| $40.4K | ﹤0.01% |
+13,461
| New | +$40.4K |
|
2020
Olaplex Holdings
OLPX
$974M
| $40.3K | ﹤0.01% |
28,812
-1,204
| -4% | -$1.69K |
|
2021
Eventbrite
EB
$253M
| $40.2K | ﹤0.01% |
15,268
-1,943
| -11% | -$5.11K |
|
2022
Cardiff Oncology
CRDF
$142M
| $40K | ﹤0.01% |
12,712
+94
| +0.7% | +$296 |
|
2023
ADC Therapeutics
ADCT
$382M
| $39.8K | ﹤0.01% |
14,855
-2,750
| -16% | -$7.37K |
|
2024
AbCellera Biologics
ABCL
$1.24B
| $38.2K | ﹤0.01% |
11,146
-2,297
| -17% | -$7.88K |
|
2025
E.W. Scripps
SSP
$266M
| $37.9K | ﹤0.01% |
12,890
-383
| -3% | -$1.13K |
|